Immunocore Holdings (IMCR) Current Leases (2019 - 2026)

Immunocore Holdings (IMCR) has reported Current Leases for 8 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.

• Quarterly Current Leases rose 16.25% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 16.25% YoY) and the FY2025 annual result came in at $2.0 million, up 29.67% from the prior year.
• Current Leases held at $2.0 million in Q1 2026 per IMCR's latest filing, from $2.0 million in the prior quarter.
• Over the last five years, Current Leases for IMCR reached as high as $2.0 million in Q4 2025 and fell as low as $1.1 million in Q3 2024.
• A 5-year average of $1.7 million and a median of $1.8 million in 2022 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2024 — Current Leases retreated 26.74% — and 2025, when it soared 71.19%.
• Year by year, Current Leases stood at $1.8 million in 2022, then retreated by 23.9% to $1.4 million in 2023, then gained by 11.46% to $1.5 million in 2024, then rose by 29.67% to $2.0 million in 2025, then fell by 0.5% to $2.0 million in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $2.0 million, $2.0 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.